Who Paid My Doc
Christina Vander Pluym
Advanced Heart Failure and Transplant Cardiology Boston, MA Medical Doctor
NPI 1366722266 CMS profile 243080
300 Longwood Ave, Boston, MA 02115
General payments
$54,551
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$396,848
Through program year 2025, Christina Vander Pluym of Boston, MA is reported in the CMS Open Payments database as having received $54,551 across 56 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $396,848 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 80th percentile of Advanced Heart Failure and Transplant Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $305 | 1 | |
| 2024 | General | $1,830 | 2 | |
| 2023 | General | $35,948 | 23 | |
| 2022 | General | $6,264 | 4 | |
| 2021 | General | $250 | 1 | |
| 2020 | General | $7,999 | 4 | |
| 2019 | General | $1,955 | 21 |
Beside peers
- Christina Vander Pluym
- Advanced Heart Failure and Transplant Cardiology median
- Middle half of Advanced Heart Failure and Transplant Cardiology
- National median
In program year 2025, general payments to Christina Vander Pluym were reported at $305. Among 967 Advanced Heart Failure and Transplant Cardiology profiles paid that year, the median was $1,024 and the middle half received between $289 and $6,890.
Show as a table
| Year | Christina Vander Pluym | Advanced Heart Failure and Transplant Cardiology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $1,955 | $863 | $224–$4,562 | $163 |
| 2020 | $7,999 | $452 | $122–$3,992 | $114 |
| 2021 | $250 | $550 | $159–$3,571 | $132 |
| 2022 | $6,264 | $729 | $221–$4,357 | $149 |
| 2023 | $35,948 | $1,002 | $309–$5,827 | $160 |
| 2024 | $1,830 | $931 | $273–$5,204 | $164 |
| 2025 | $305 | $1,024 | $289–$6,890 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
56 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Advanced Heart Failure and Transplant Cardiology in Massachusetts
Pablo Quintero Pinzon
Advanced Heart Failure and Transplant Cardiology · Boston, MA
Sophia Airhart
Advanced Heart Failure and Transplant Cardiology · Springfield, MA
Daniel Zlotoff
Advanced Heart Failure and Transplant Cardiology · Boston, MA
Adam Saltzman
Advanced Heart Failure and Transplant Cardiology · Fall River, MA
Richard Patten
Advanced Heart Failure and Transplant Cardiology · Burlington, MA
Monica Ahluwalia
Advanced Heart Failure and Transplant Cardiology · Boston, MA
Related records
Advanced Heart Failure and Transplant Cardiology in Massachusetts
Practitioners in the same specialty and state, ranked by reported value.
All Advanced Heart Failure and Transplant Cardiology
Everyone recorded under this specialty, nationwide.
Doctors in Massachusetts
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.